Literature DB >> 9773962

Isolation of the intact molecule and ectodomain of C-erbB-2 oncoprotein from SK-BR-3 cells and development of immunoassays on microplate.

J T Wu1, P Zhang, B W Lyons, L H Wu.   

Abstract

We isolated both the intact molecule (p185) and the ectodomain (p120) of c-erbB-2 oncoprotein from SK-BR-3 breast tumor cells. The p120 was extracted from the cells by 0.05 M phosphate buffer, pH 7.2, whereas the extraction of the p185 required the presence of a detergent, such as 1% Triton X-100 in 0.05 M Tris buffer. Protease inhibitors were also included in the extraction buffer during the isolation of p185 in order to prevent cleavage of p185 to p120 by an unknown protease apparently also present in the extract. In case there was any p120 in the p185 preparation, the p120 could be separated from p185 by chromatography on a Superose 12 column. Using the p120 and p185 as calibrators, we have established two microplate sandwich immunoassays: one measures both p185 and p120 (total assay) and the other is specific for the p185. Since capturing and detecting antibodies used in the total assay react against the extracellular domain of the c-erbB-2 oncoprotein, they can therefore be used to measure the p120 in serum and p185 in breast tumor tissue cytosol. On the other hand, the p185 specific assay uses the capturing antibody against the cytosolic domain of the oncoprotein and consequently can only measure p185 in breast tumor tissue cytosol.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773962      PMCID: PMC6807824          DOI: 10.1002/(sici)1098-2825(1998)12:5<298::aid-jcla9>3.0.co;2-2

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

1.  A soluble protein related to the HER-2 proto-oncogene product is released from human breast carcinoma cells.

Authors:  Y Z Lin; G M Clinton
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

2.  The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3.

Authors:  J R Zabrecky; T Lam; S J McKenzie; W Carney
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

3.  Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.

Authors:  M C Paterson; K D Dietrich; J Danyluk; A H Paterson; A W Lees; N Jamil; J Hanson; H Jenkins; B E Krause; W A McBlain
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

4.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Measurement of c-erbB-2 proteins in sera from patients with carcinomas and in breast tumor tissue cytosols: correlation with serum tumor markers and membrane-bound oncoprotein.

Authors:  J T Wu; M E Astill; S D Gagon; L Bryson
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification.

Authors:  D J Venter; N L Tuzi; S Kumar; W J Gullick
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321

8.  The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.

Authors:  A L Schechter; D F Stern; L Vaidyanathan; S J Decker; J A Drebin; M I Greene; R A Weinberg
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

9.  The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3.

Authors:  O Alper; K Yamaguchi; J Hitomi; S Honda; T Matsushima; K Abe
Journal:  Cell Growth Differ       Date:  1990-12

10.  In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells.

Authors:  S Mori; Y Mori; T Mukaiyama; Y Yamada; Y Sonobe; H Matsushita; G Sakamoto; T Akiyama; M Ogawa; M Shiraishi
Journal:  Jpn J Cancer Res       Date:  1990-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.